Literature DB >> 14263500

THE FATE OF PSEUDOMONAS AERUGINOSA, PROTEUS MIRABILIS AND ESCHERICHIA COLI IN THE MOUSE KIDNEY.

R H GORRILL.   

Abstract

Entities:  

Keywords:  ESCHERICHIA COLI INFECTIONS; EXPERIMENTAL LAB STUDY; KIDNEY FUNCTION TESTS; MICE; PROTEUS INFECTIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYELONEPHRITIS

Mesh：

Year:  1965        PMID： 14263500     DOI： 10.1002/path.1700890110

Source DB:  PubMed          Journal:  J Pathol Bacteriol        ISSN： 0368-3494


× No keyword cloud information.
  8 in total

Review 1.  Microbial ureases: significance, regulation, and molecular characterization.

Authors:  H L Mobley; R P Hausinger
Journal:  Microbiol Rev       Date:  1989-03

Review 2.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

3.  Experimental urinary tract infection with Pseudomonas aeruginosa in mice.

Authors:  T Nishi; K Tsuchiya
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

4.  Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection.

Authors:  B D Jones; C V Lockatell; D E Johnson; J W Warren; H L Mobley
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  H-NS is a repressor of the Proteus mirabilis urease transcriptional activator gene ureR.

Authors:  C Coker; O O Bakare; H L Mobley
Journal:  J Bacteriol       Date:  2000-05       Impact factor: 3.490

6.  Virulence of Escherichia coli in experimental hematogenous pyelonephritis in mice.

Authors:  J F van den Bosch; J de Graaff; D M MacLaren
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

7.  Rat pyelonephritis model suitable for primary or secondary screening.

Authors:  S E Burrous; J B Cawein
Journal:  Appl Microbiol       Date:  1969-09

8.  Reduced resistance to Pseudomonas septicaemia in diabetic mice.

Authors:  Y Kitahara; T Ishibashi; Y Harada; M Takamoto; K Tanaka
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.